Actively Recruiting
Development of a Cortical Visual Neuroprosthesis for the Blind
Led by Universidad Miguel Hernandez de Elche · Updated on 2026-05-05
5
Participants Needed
2
Research Sites
469 weeks
Total Duration
On this page
Sponsors
U
Universidad Miguel Hernandez de Elche
Lead Sponsor
H
Hospital IMED Elche
Collaborating Sponsor
AI-Summary
What this Trial Is About
The objective of this study is to evaluate the usefulness of a cortical visual prosthesis based on intracortical microelectrodes to provide a limited but useful sense of vision to profoundly blind. This pilot study will provide important information on safety and efficacy for the development of an useful cortical visual neuroprosthesis for the blind.
CONDITIONS
Official Title
Development of a Cortical Visual Neuroprosthesis for the Blind
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participant is capable and willing to provide informed consent for participation in the trial.
- Severe visual impairment with bilateral visual loss.
- Greater than 18 years of age.
- General health: excellent.
- Following a general physical and neurological examination, patient must have normal serum electrolytes, C-reactive protein, complete blood count and PT and PTT.
- No history of stroke, seizure, coagulopathy, cardiac arrhythmias or ischemia, pulmonary, hepatic or renal disease, nor transmissible viruses such as hepatitis or HIV.
- Stable dose of current regular medication for at least four weeks prior to trial entry.
- Able to perform the study during the full time period of up to 6 months.
You will not qualify if you...
- Age less than 18 or greater than 70.
- Period of appropriate visual functions less than 12 years during lifetime.
- History of seizure disorders, coagulopathy, cardiac arrhythmias or ischemia, pulmonary, hepatic or renal disease, and any other neurological disorder.
- Patients who carry a transmissible virus such as hepatitis and individuals with HIV-related neuropathies.
- Vulnerable subject groups such as pregnant women and prisoners.
- Persons unable to give written informed consent prior to participation.
- Not able to perform the study during the full time period (at least 3 months).
- Any other significant disease or disorder which may put the participant at risk, influence study results, or limit participation.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Hospital IMED Elche
Elche, Alicante, Spain, 03202
Actively Recruiting
2
Universidad Miguel Hernandez de Elche
Elche, Alicante, Spain, 03202
Actively Recruiting
Research Team
E
Eduardo Fernandez, MD and PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here